Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.

Oleg KurtenkovJelena IzotovaKersti KlaamasBoris Sergeyev

Published in: BioMed research international (2014)

Our findings are the first evidence that the increased sialylation of TF-specific Abs combined with a low level of anti-TF IgM is strongly linked to gastric cancer and patients survival, which can be used as a novel biomarker for cancer detection and prognosis.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
papillary thyroid
peritoneal dialysis
risk assessment
young adults
patient reported outcomes
label free
climate change
lymph node metastasis
quantum dots
loop mediated isothermal amplification